The 20S proteasome α3 is an essential component of the proteasome complex, a crucial element in the ubiquitin-proteasome system (UPS) responsible for protein degradation within cells. This system plays a vital role in maintaining cellular homeostasis by degrading misfolded, damaged, or unneeded proteins, thus preventing their accumulation which can be detrimental to cell health. The 20S proteasome α3, specifically, is part of the core proteolytic chamber of the proteasome, where targeted proteins are broken down into peptides. This process is critical for the regulation of various cellular processes, including cell cycle progression, signal transduction, and stress responses. By ensuring the timely degradation of specific proteins, the 20S proteasome α3 contributes to the control of numerous physiological processes, making it an integral player in maintaining the cell's internal environment and response to external stimuli.
Activation of the 20S proteasome α3, and the proteasome in general, involves a complex interplay of regulatory mechanisms that ensure its proteolytic activities are conducted precisely and efficiently. Unlike transcriptional activation or upregulation of expression, which are indirect and involve changes in protein synthesis levels, the functional activation of the proteasome refers to the enhancement of its protein-degrading activity. This can be achieved through post-translational modifications, such as phosphorylation, or through the binding of regulatory particles that prepare substrates for degradation or alter the proteasome's activity. The 20S core itself is regulated by the association with 19S or 11S regulatory particles, which dictate the entry of substrates into the core particle. Moreover, the cellular context, including stress signals or the presence of damaged proteins, can trigger adaptations in proteasome activity. These regulatory mechanisms ensure that the proteasome's activity is modulated according to the cell's needs, allowing it to respond dynamically to changes in the cellular environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Lactacystin, by irreversibly binding to the proteasome, inhibits its proteolytic functions. This blockade results in a feedback increase in the expression of proteasome subunits, including the 20S Proteasome α3, indirectly activating its enzymatic activity. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Epoxomicin selectively inhibits the proteasome's catalytic activity, which induces a cellular response to increase the expression of proteasome components, including the 20S Proteasome α3, thus indirectly enhancing its ability to degrade proteins. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Ixazomib binds reversibly to the proteasome, reducing its activity. This action prompts a compensatory upregulation of proteasome subunits, including 20S Proteasome α3, thus indirectly enhancing its functional activity in protein degradation. | ||||||